US$ 26.87
benefits of glp-1 receptor agonists in Heart Failure Management Current Insights, Advantages and Challenges
Description
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9) Diabetes, Obesity and Metabolism

Kulldorff, M

Kulcsar K, Coleman C, Beck S, Frieman M

That complexity directly correlates with the quality variation you see across vendors

Do not take an extra dose if you miss one
